Background. Trichomonas vaginalis (TV) is the most common nonviral sexually transmitted infection (STI) in the world. However, TV is not a reportable STI and, with the exception of HIV-positive women, there are no guidelines for screening in women or men. The objective of this study was to determine the added value of nucleic acid amplification tests (NAATs) for detection of TV in men and women at high risk for infection as well as correlates of infection.
TV has been shown to be associated with increased susceptibility to human immunodeficiency virus (HIV) [13] and adverse pregnancy outcomes [14] . TV is not a reportable STI; with the exception of HIV-positive women [15] , there are no guidelines for screening in women or men. TV is most frequently diagnosed by examination of a wet mount of vaginal fluid, which has a sensitivity of 50%-60% [16, 17] ; wet mount of urethral secretions in men is less reliable and not routinely practiced [7] . The gold standard for TV diagnosis in women has been culture of vaginal fluid, which requires incubation and is categorized by the Clinical Laboratory Improvement Amendments (CLIA) as moderately complex [18] ; the optimal site or specimen for diagnosis in men using culture is unknown [19] . TV culture is not readily available in clinical settings and sensitivity is less compared to the recently available, highly sensitive nucleic acid amplification test (NAAT) [20] . The TV NAAT has been validated in asymptomatic and symptomatic women in multiple specimen types [21, 22] and is run on the same instrumentation platforms for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) testing [21] [22] [23] . Although the TV NAAT can be used to test male urethral and urine specimens, US Food and Drug Administration clearance has not been sought for this purpose [23] .
The Jefferson County Department of Health Sexually Transmitted Diseases (STD) Clinic in Birmingham, Alabama, implemented routine TV NAAT testing on endocervical, urine, and urethral specimens collected from women and men presenting to the clinic in March 2012 (women) and November 2012 (men). All women have a wet mount of vaginal fluid. Prior to implementation of NAAT, no TV testing was available for men, as only Gram staining of urethral discharge is performed. Our primary objective was to determine the added value of NAAT for TV detection in men and women as well as correlates of infection. We also sought to compare clinical and laboratory characteristics of women that were TV wet mount positive, NAAT positive with those that were TV wet mount negative, NAAT positive, as we sought to develop an algorithm for targeted TV NAAT use in women with a negative wet mount for TV.
METHODS
This study was approved by the Institutional Review Board at the University of Alabama at Birmingham and by the Jefferson County Department of Health. Patients presenting to the STD Clinic and receiving a TV NAAT between March 2012 and September 2013 were identified from the electronic medical record. This clinic serves a lower-income, minority (>90% African American) population; patients are asked to pay $5 to see a clinician and receive STI testing. Inclusion criteria included age ≥16 years and receipt of a TV NAAT on an endocervical or urine specimen between March 2012 and September 2013 (women) and on a urethral or urine specimen between November 2012 and September 2013 (men). Only data from the first clinic visit per patient during this time frame were reviewed.
Variables abstracted included age, race, circumcision status, urogenital symptoms, and current clinical diagnoses at the time of clinic visit: cervicitis, pelvic inflammatory disease, bacterial vaginosis (BV) (based on Amsel criteria [24] ), and vulvovaginal candidiasis. Laboratory variables included vaginal pH, whiff test (presence of a fishy odor when 10% potassium hydroxide is added to a sample of vaginal discharge), presence of trichomonads, clue cells (squamous epithelial cells coated with anaerobic bacteria that have sloughed off from the vaginal epithelium), and white blood cells (WBCs) per high-power field (HPF) on vaginal wet mount ( point-of-care test in women), number of polymorphonuclear cells (PMNs) on urethral Gram stain per HPF ( point-of-care test in men), and TV, CT, and GC NAAT results on endocervical, urethral, or urine specimens using the Gen-Probe Aptima Combo 2 assay (GenProbe, San Diego, California) (send out test, results take 7 days). It was also noted whether patients with TV were treated with metronidazole ( provided at no additional charge by the clinic and given on site) at the time of their clinic visit on the day in which the TV NAAT was obtained, presumably either due to a positive wet mount for TV (women), clinical diagnosis of BV (women), or because they were a contact to TV (women and men). At this clinic, asymptomatic and symptomatic patients with a positive TV NAAT are asked to return for treatment if they had not already received metronidazole on the day in which the NAAT was obtained.
Statistical analyses were performed using Stata 12.1 (StataCorp, College Station, Texas). The association of demographic and clinical characteristics with TV infection was examined separately for women and men, with logistic regression used to calculate odds ratios (ORs) and confidence intervals (CIs) in unadjusted and adjusted models. All variables of interest were first examined separately in unadjusted models to assess bivariate associations. The adjusted models include all variables observed to be significant at P < .05 in the unadjusted analyses.
RESULTS
Data were available for 6335 patients: 3821 women and 2514 men. The majority were aged 25-40 years and most (86%) were African American (Table 1) . Based on NAAT results, the overall prevalence of TV was 1279 of 6335 (20.2%); TV prevalence by sex was 1032 of 3821 (27.0%) among women and 247 of 2514 (9.8%) among men. TV prevalence by wet mount among women was 736 of 3765 (19.6%). This was significantly lower than the 27.0% prevalence found among women using NAAT (P < .001), signifying that NAAT detected approximately one-third more infections among women than wet mount.
A total of 3765 women had both wet mount and NAAT results available (wet mount results were not available for 56 women). Of these women, 317 had discordant results, including 301 who were TV negative according to wet mount but TV positive according to NAAT (false-negative wet mounts) and 16 who were TV positive according to wet mount but TV negative according to NAAT (false-positive wet mounts , although concurrent CT was not. After adjusting for other significant variables in each of the models for men and women, all correlates found to be significant in unadjusted analyses remained significant in adjusted models (Tables 2 and 3 ) except for the presence of urogenital symptoms in women, which became nonsignificant.
The proportion of women that were TV wet mount negative, NAAT positive was 29.5% (301/1021). Table 4 
DISCUSSION
This is one of the first studies to report TV prevalence and correlates of infection among men and women attending an STD clinic in which a TV NAAT was obtained during routine care. In this relatively large clinic population, TV prevalence (based on NAAT) was 27.0% in women and 9.8% in men. This prevalence in women is significantly higher than the 3.2% (as Other race/ethnicity includes American Indian or Alaska Native (n = 5), Asian (n = 14), Native Hawaiian or other Pacific Islander (n = 4), multiple races (n = 9), or unreported/refused to answer (n = 21). b Diagnosed by NAAT on urethral or urine specimens for men and endocervical or urine specimens for women. Overall prevalence of TV infection among all patients in the sample was 20.2%.
determined by polymerase chain reaction) reported in the 2001-2004 National Health and Nutrition Examination Survey (NHANES), the most recent study of TV prevalence in the United States [25] . It is also higher than in other STD clinic populations (2%-18%) [26] [27] [28] [29] , including previous studies performed at this clinic using wet mount [20] . This is likely due to the improved sensitivity of NAAT compared with other diagnostic methods. Using data collected from 15 STD clinics, Meites et al found that TV prevalence (determined by wet mount, culture, NAAT, or any other type of test) among symptomatic women was 26.2% [30] . TV prevalence among women in our study (27.0%) was similar but included both symptomatic and asymptomatic women. The lower TV prevalence found among men in our study, compared with women, is likely influenced by the high rate (36%-69%) of spontaneous resolution of TV that is known to occur in men [19, 31] . Prevalence of TV based on wet mount among women was 19.6%, suggesting that TV would have gone undiagnosed in approximately onethird of infected women had NAAT not been performed.
Correlates of TV among men and women based on NAAT included age (>40 years) and African American race, similar to previous studies [3-5, 8, 12] . Unlike CT and GC [32] , older age is a significant risk factor for TV in men and women [4] , perhaps due to accumulating infections caused by lack of detection. Potential reasons for the racial disparity have been previously discussed [5] , although the fact that the majority of patients seen in our clinic are of African American race may have also influenced this finding. Among men, having ≥5 PMNs per HPF (suggestive of NGU) on urethral Gram stain was also correlated with TV; TV is known to be an important cause of NGU [19] . Additional correlates of TV among women included leukorrhea on wet mount, similar to that noted by Lazenby et al [33] , elevated vaginal pH (TV prefers a high pH for optimal growth) [18] , positive whiff test, and concurrent gonococcal infection. Among men and women with a positive TV NAAT, 40 .1% of men and 16.4% of women had not been treated with metronidazole at the time of their initial clinic visit, signifying missed opportunities for treatment.
It is noteworthy that the presence of urogenital symptoms among men and women was not correlated with TV. This is consistent with the findings of Nye et al, which showed that no symptoms were specific for any positive TV test [20] . In addition, similar to others [20] , the results of our study suggest that TV can often be a subclinical infection, as approximately one-third of women with TV-positive results based on wet mount and one-third of women with TV-positive results based on NAAT did not complain of urogenital symptoms at the time of their clinic visit.
We also found that TV was not associated with BV among women. It has been suggested that TV may alter the vaginal microbiota in a manner that is favorable to its survival and transmissibility [34] . Hillier et al found that pregnant women with intermediate Nugent scores [35] had the highest prevalence of TV [36] . Martin et al corroborated this finding in a subset of 394 at a prior visit is associated with 1.5-to 2-fold increased risk for incident TV among a cohort of 3620 nonpregnant women [37] . In vitro data suggest that TV grows better in an elevated pH [38] ; BV can provide this high-pH environment. TV itself may also be able to manipulate the vaginal environment and promote changes in the vaginal flora, leading to an elevated pH. Indeed, the majority of women (82.9%) testing positive for TV (based on NAAT) in our study had an elevated vaginal pH (Table 3) . Although a clinical diagnosis of BV was not correlated with TV, it would have been of interest to look at the distribution of Nugent scores among women testing TV positive to see if they were in the abnormal range. However, we did not have these data available. An unexpected finding was that concurrent CT and GC were associated with reduced likelihood of TV among men.
Explanations for this are unknown, although it could be related to cumulative asymptomatic infection caused by TV in men as opposed to symptomatic infection with CT or GC whereby men would actively seek care at an STD clinic. Indeed, only 72 of 247 (29.1%) of men in this study positive for TV by NAAT had complaints of urogenital symptoms (Table 2) . Unfortunately, we did not have the data available to know whether or not men testing positive for TV reported being a contact to TV upon presenting to the clinic; however, the fact that 59.5% were treated with metronidazole at the time of their visit strongly suggests this. Conversely, concurrent GC was positively associated with increased likelihood of TV among women. It has been reported that TV is associated with GC in women 8%-50% of the time and that GC prevalence is 1.4-1.9 times higher in women with TV than in women without TV [39] . This correlation between TV and GC has also been noted by Lossick in a study of 3507 TV cases [40] and Lazenby et al in Abbreviations: CI, confidence interval; HPF, high-powered field; OR, odds ratio; PID, pelvic inflammatory disease; TV, Trichomonas vaginalis; WBC, white blood cell. a Diagnosed by nucleic acid amplification test (NAAT) on endocervical (n = 3125) or urine (n = 688) specimens. Source of NAAT specimen was missing for 8 patients.
b Urogenital symptoms includes those patients with vaginal discharge (n = 1729), vaginal odor (n = 1315), and/or dysuria (n = 301). a study of 294 women, of whom 16% had TV [33] . Similar to our results, a correlation between TV and CT has not been noted in prior studies [40] . The biologic and/or social differences that account for these findings are unknown. It could be hypothesized that the demographic pool of CT infections among women may be more diffuse than the pool of TV/GC infections and that risk factors for acquiring CT are different than those for acquiring TV/GC [40] . We originally hypothesized that women with TV wet mountnegative, NAAT-positive results would have a lower burden of disease due to TV and be less likely to have urogenital symptoms, elevated vaginal pH, and leukorrhea on wet mount than women with TV wet mount-positive, NAAT-positive results. The results of our study are somewhat consistent with this as women with an elevated vaginal pH and leukorrhea had lower odds of having results that were TV wet mount negative, NAAT positive. Women with urogenital symptoms initially also had a lower odds of having TV wet mount-negative, NAAT-positive results, although this finding lost its significance in adjusted analysis. Only concurrent gonococcal infection was found to be significantly correlated with TV wet mount negativity, NAAT positivity. The biologic basis for this unexpected finding is unknown. In terms of algorithmic testing, the results of our study suggest that patients with an elevated pH and leukorrhea on wet mount should be evaluated with a more sensitive TV diagnostic test, preferably NAAT, particularly if microscopy is negative for TV. Clearly, all STD clinic clients should be screened for TV and reflex testing in general; that is, NAATs (particularly if wet mount is negative), could be used as a cost-saving measure.
Our study has several limitations. First, data were collected retrospectively, limiting the amount of sexual history (including reason for clinic visit), clinical diagnosis, and laboratory data (including HIV testing results) able to be extracted. Because of this, there may be additional correlates of TV not identified here. Second, the results of this study were obtained from one STD clinic in the southern United States and may not be generalizable to other clinical settings. Additionally, as only data from the first clinic visit per patient during the study time frame was reviewed, we were unable to determine whether men and women with TV had a new infection vs a persistent f Diagnosed by NAAT on endocervical (n = 3125) or urine (n = 688) specimens. Source of NAAT specimen was missing for 8 patients.
or recurrent infection. Because of this, we were also unable to determine the exact percentage of patients with a positive TV NAAT who received treatment with metronidazole as we only had data available from the clinic visit on the day in which the NAAT was obtained. Nevertheless, this study demonstrates that routine implementation of TV NAAT at our STD clinic was able to detect a significant proportion of infected male and female patients, significantly higher than that detected by wet mount alone in women. The TV NAAT can easily be implemented in clinical settings as it can be run on the same instrumentation platforms available for CT and GC testing. Improved detection of TV by implementation of NAAT in men and women of all age groups should be considered, as it will likely result in better control of this common, treatable STI.
Notes

